Revance Securities Settlement
Not yet determinable; depends on number of valid claims submitted
What happened
Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.
Do you qualify?
Anyone who purchased or acquired Revance Therapeutics common stock (ticker "RVNC") or 1.75% fixed coupon Convertible Senior Unsecured Notes between February 29, 2024 through the close of the merger on February 6, 2025, inclusive.
How to file
File a Proof of Claim and Release Form by August 28, 2026, either by mail (postmarked by deadline) or online. You must provide documentation of your purchase or acquisition of Revance securities.
Common questions
- How much does the Revance Securities Settlement pay?
- Estimated payout: Not yet determinable; depends on number of valid claims submitted. The total settlement fund is $17M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
- What is the claim deadline for the Revance Securities Settlement?
- The claim deadline is August 28, 2026. Filing is free and is done on the official settlement website at revancesecuritiessettlement.com.
- Do I need proof of purchase for the Revance Securities Settlement?
- Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.
- Is the Revance Securities Settlement notice real, or a scam?
- Claims Administrator (not named) is the settlement administrator for this case. Claims are filed at revancesecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- How long until I get paid from the Revance Securities Settlement?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for August 10, 2026; no payments can be issued before a settlement receives final approval.
- What happens if I do nothing?
- You receive no payment, and in most class actions you also give up the right to sue Revance Therapeutics, Inc., Mark J. Foley, and Tobin C. Schilke separately over these same claims. To keep that right you must opt out (exclude yourself) by July 13, 2026.
Who's involved
Plaintiffs
- Chicago Capital Management, LP
- iMGP Alternative Strategies Fund
- AltShares Event-Driven ETF
- AltShares Merger Arbitrage ETF
- The Arbitrage Fund
- Aabash Pokhrel
- Cassandra Matney
Defendants
- Tobin C. Schilke
- Mark J. Foley
- Revance Therapeutics, Inc.
Counsel for plaintiffs
- Vincent R. CappucciEntwistle & Cappucci LLP
- Robert N. CappucciEntwistle & Cappucci LLP
- Callie CrispinEntwistle & Cappucci LLP
- Brendan J. BrodeurEntwistle & Cappucci LLP
- Andrew J. EntwistleEntwistle & Cappucci LLP
- James Gerard Stranch , IVStranch, Jennings & Garvey, PLLC
- James A. Holifield , Jr.Holifield & Janich PLLC
- Joseph Dylan HarperHoltzman Vogel
- Robert P. BramlettBramlett Law Offices
- Paul Kent BramlettBramlett Law Offices
- Joshua E. FruchterWohl & Fruchter LLP
- Jeremy A. LiebermanPomerantz LLP (NY Office)
- J. Alexander Hood , IIPomerantz LLP (NY Office)
Counsel for defendants
- Susan L. SaltzsteinSkadden, Arps, Slate, Meagher & Flom LLP (New York)
- Milton S. McGee , IIIRiley & Jacobson, PLC
- Jordan D. PetersonKirkland & Ellis (NY)
- Jenness E. ParkerSkadden, Arps, Slate, Meagher & Flom, LLP
- Jeffrey S. GeierSkadden, Arps, Slate, Meagher & Flom LLP (New York)
- Christopher E. ThorsenBaker, Donelson, Bearman, Caldwell & Berkowitz, PC (Nash)
- Christopher R. FredmonskiSkadden, Arps, Slate, Meagher & Flom LLP (New York)
Parties and counsel from the public court docket. Listing an attorney here isn't an endorsement, and ClaimWatch isn't affiliated with any of them.
In the news
- Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Revance Therapeutics, Inc. Investors in Securities Fraud Class Action LawsuitYahoo Entertainment · December 30, 2021
- Revance Therapeutics, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More InformationYahoo Entertainment · December 30, 2021
- RVNC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 8, 2022 Deadline Reminder for Revance Therapeutics, Inc.Yahoo Entertainment · December 25, 2021
- DEADLINE: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RVNCYahoo Entertainment · December 15, 2021
Headlines via NewsAPI. ClaimWatch isn't affiliated with these publications.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Biogen Securities Litigation Settlement
Biogen Inc. investors have settled a securities litigation case for $18.9 million in cash. The settlement resolves claims related to purchases of Biogen common stock during the specified class period.
NJ Bureau of Securities Settlement with Credit Suisse
Credit Suisse allegedly violated New Jersey Securities Law by making materially false and misleading statements regarding RMBS trust certificates and engaging in fraudulent practices. On October 24, 2022, the court entered a consent order requiring Credit Suisse to pay $300 million in restitution to investors. Credit Suisse neither admitted nor denied the allegations.
Stitch Fix Securities Litigation Settlement
Stitch Fix, Inc. is settling a securities class action lawsuit without admitting wrongdoing. The Lead Plaintiffs alleged that Stitch Fix issued misleading statements about its business, and shareholders who purchased the stock during the class period suffered damages as a result.
Vintage Wine Securities Settlement
Vintage Wine Estates, Inc. allegedly violated federal securities laws. The defendants deny any wrongdoing and assert that no damages were suffered. The settlement resolves these claims for $7.5 million.
Up to $0.79